시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 근육통 치료 시장 보고서(2025년)
Muscle Pain Treatment Global Market Report 2025
상품코드 : 1825825
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

근골격계 질환의 유병률 증가로 인해 근육통 치료 시장은 성장할 것으로 예상됩니다. 근골격계 질환은 근육, 뼈, 관절에 영향을 미쳐 통증, 경직, 운동 제한을 유발합니다. 인구의 고령화, 좌식 생활습관, 만성질환의 증가 등을 원인으로 꼽을 수 있습니다. 치료는 통증 완화, 이동성 개선, 합병증 예방, 전반적인 삶의 질과 기능 향상을 통해 증상을 완화하는 것을 목표로 합니다. Lancet지 2023년 11월 조사에 따르면, 2020년 전 세계적으로 약 4억 9,400만 명이 근골격계 질환을 경험했으며, 2050년에는 115% 증가할 것으로 예측됩니다. 그 결과, 근육통 치료 시장은 확대되고 있습니다.

이 시장의 주요 기업들은 효과와 편의성을 향상시키기 위해 국소 진통제 등의 제품을 개발하며 기술 혁신을 진행하고 있습니다. 이 의약품은 피부에 직접 바르면 대상 부위의 통증을 완화하는 것으로 근육통, 관절염, 경미한 부상 등에 자주 사용됩니다. 예를 들어, 2024년 7월 Wellness Formulations LLC는 진통용 멘톨과 고급 침투 촉진제 및 피부 컨디셔너를 특징으로 하는 Ralli Rapid Pain Relief를 출시하였습니다. 젤, 스프레이, 롤온 타입이 있으며, 근육통, 관절통, 관절염, 염좌, 염좌를 빠르고 오랫동안 완화시켜 줍니다. 따라서 환부에 직접 바를 수 있으며, 마사지나 마사지를 할 필요가 없습니다.

2022년 2월, 미국에 본사를 둔 물리치료 및 정형외과 재활 서비스를 제공하는 애슬레티코 피지컬 테라피(Athletico Physical Therapy)가 피벗 헬스 솔루션(Pivot Health Solutions)을 미공개 금액으로 인수했습니다. 이러한 전략적 움직임은 지리적 범위를 확장하고 물리치료 및 작업 위생 역량을 강화함으로써 근육통 치료 시장에서 애슬레티코의 입지를 강화할 것입니다. 이번 인수는 또한 애슬레티코에 숙련된 리더십을 제공하고, 높은 수준의 환자 치료를 제공하겠다는 약속을 강화할 것입니다. 미국에 본사를 둔 피벗 헬스 솔루션은 물리치료, 산업보건, 현장 기업 건강 서비스를 전문으로 하는 회사로 근육통 및 기타 신체 질환의 치료에 중점을 두고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Treatment for muscle pain involves managing and easing discomfort and inflammation in muscles. This typically includes rest, applying heat or cold therapy, using over-the-counter pain relievers, and sometimes undergoing physical therapy or taking prescription medications for more severe cases. The goal of effective treatment is to reduce pain, facilitate healing, and restore normal muscle function.

Pharmacological approaches to treating muscle pain include analgesics, muscle relaxants, topical analgesics, and other medications. Analgesics are drugs specifically designed to alleviate pain without causing unconsciousness. Non-pharmacological treatments encompass physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise, stretching, and other methods. These treatments target various types of pain, such as acute and chronic muscle pain resulting from overuse, injury, inflammation, neurological conditions, infections, and other causes. They are administered in various settings, including hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The muscle pain treatment market research report is one of a series of new reports from The Business Research Company that provides muscle pain treatment market statistics, including muscle pain treatment industry global market size, regional shares, competitors with a muscle pain treatment market share, detailed muscle pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. This muscle pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The muscle pain treatment market size has grown steadily in recent years. It will grow from $12.95 billion in 2024 to $13.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to aging population with a higher incidence of chronic pain conditions, an increase in sports injuries due to higher participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain.

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $16.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, emphasis on preventive healthcare to mitigate chronic pain conditions, and growing demand for alternative therapies like acupuncture and chiropractic care. Major trends in the forecast period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of electromyography (EMG) devices and compounded pain creams sourced from Canada and Italy, thereby limiting non-opioid treatment options and elevating physical medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The muscle pain treatment market is expected to grow due to the increasing prevalence of musculoskeletal disorders. Musculoskeletal disorders affect the muscles, bones, and joints, causing pain, stiffness, and limited movement. Factors contributing to rising cases include aging populations, sedentary lifestyles, and the increasing incidence of chronic conditions. Treatment aims to alleviate symptoms by reducing pain, improving mobility, preventing complications, and enhancing overall quality of life and function. According to a November 2023 study by The Lancet, an estimated 494 million people globally experienced musculoskeletal disorders in 2020, with projections suggesting a potential 115% increase by 2050. As a result, the muscle pain treatment market is expanding.

Leading companies in this market are innovating by developing products such as topical analgesics to improve effectiveness and user convenience. These medications are applied directly to the skin to relieve pain in targeted areas, commonly used for muscle aches, arthritis, and minor injuries. For example, in July 2024, Wellness Formulations LLC introduced Ralli Rapid Pain Relief, featuring menthol for pain relief along with advanced penetration enhancers and skin conditioners. Available in gel, spray, and roll-on formats, it offers quick and long-lasting relief from muscle aches, joint pain, arthritis, strains, and sprains, without leaving a greasy residue. This allows for easy application directly to affected areas, eliminating the need for rubbing or massaging.

In February 2022, Athletico Physical Therapy, a US-based provider of physical therapy and orthopedic rehabilitation services, completed the acquisition of Pivot Health Solutions for an undisclosed sum. This strategic move strengthens Athletico's position in the muscle pain treatment market by expanding its geographic reach and enhancing capabilities in physical therapy and occupational health. The acquisition also brings seasoned leadership to Athletico and reinforces its commitment to delivering high standards of patient care. Pivot Health Solutions, also based in the US, specializes in physical therapy, occupational health, and onsite corporate health services, focusing on treating muscle pain and other physical ailments.

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy

North America was the largest region in the muscle pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Muscle Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscle pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for muscle pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The muscle pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Muscle Pain Treatment Market Characteristics

3. Muscle Pain Treatment Market Trends And Strategies

4. Muscle Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Muscle Pain Treatment Growth Analysis And Strategic Analysis Framework

6. Muscle Pain Treatment Market Segmentation

7. Muscle Pain Treatment Market Regional And Country Analysis

8. Asia-Pacific Muscle Pain Treatment Market

9. China Muscle Pain Treatment Market

10. India Muscle Pain Treatment Market

11. Japan Muscle Pain Treatment Market

12. Australia Muscle Pain Treatment Market

13. Indonesia Muscle Pain Treatment Market

14. South Korea Muscle Pain Treatment Market

15. Western Europe Muscle Pain Treatment Market

16. UK Muscle Pain Treatment Market

17. Germany Muscle Pain Treatment Market

18. France Muscle Pain Treatment Market

19. Italy Muscle Pain Treatment Market

20. Spain Muscle Pain Treatment Market

21. Eastern Europe Muscle Pain Treatment Market

22. Russia Muscle Pain Treatment Market

23. North America Muscle Pain Treatment Market

24. USA Muscle Pain Treatment Market

25. Canada Muscle Pain Treatment Market

26. South America Muscle Pain Treatment Market

27. Brazil Muscle Pain Treatment Market

28. Middle East Muscle Pain Treatment Market

29. Africa Muscle Pain Treatment Market

30. Muscle Pain Treatment Market Competitive Landscape And Company Profiles

31. Muscle Pain Treatment Market Other Major And Innovative Companies

32. Global Muscle Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Pain Treatment Market

34. Recent Developments In The Muscle Pain Treatment Market

35. Muscle Pain Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기